Clinical Trials in San Antonio

Showing 7621-7640 of 11,125 trials

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

NCT03394677

This is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.

Atopic Dermatitis

Dermavant Sciences GmbH110 participantsStarted Jan 2018

Los Angeles, California, United States • Oklahoma City, Oklahoma, United States • Portland, Oregon, United States +4 more locations

TERMINATEDPhase 1< 1 mile

Study of Samalizumab in Patients With Advanced Cancer

NCT02987504

This is a multicenter, open-label, dose-escalation, Phase 1 study of intravenous (IV) samalizumab to determine its maximum tolerated dose (MTD), overall safety/tolerability, pharmacokinetic and pharmacodynamic parameters, and efficacy in participants with advanced cancer. The study was terminated for administrative reasons and not due to any safety concerns.

Advanced Solid Tumors

Alexion Pharmaceuticals, Inc.10 participantsStarted Nov 2016

New Haven, Connecticut, United States • Grand Rapids, Michigan, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Eslicarbazepine Acetate Monotherapy Long Term Study

NCT00910247

This is a long term, open-label, safety extension study in subjects with partial onset seizures.

Epilepsy

Sumitomo Pharma America, Inc.274 participantsStarted Aug 2009

Northport, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +119 more locations

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Study of Samalizumab in Patients With Advanced Cancer

Eslicarbazepine Acetate Monotherapy Long Term Study

Find Trials by Condition in San Antonio

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

The Advocate Study

Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

Evaluation of ClearLLab Leukemia and Lymphoma Panels

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Pharmacist-led Group Medical Visits to Help With Diabetes Management